Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums.
The number of new cases in nervous system cancer was 6.4 per 100,000 men and women per year. The number of deaths for both men and women was 4.3 per 100,000 per year. These rates are age-adjusted and based on 2010-2014 cases and deaths. Based on 2011-2012 date there was approximately 0.6 % of men and women being diagnosed with brain and nervous system at some point during their lifetime. In the year 2012, there were an estimated 148,818 people living with brain cancer and other nervous system cancer in the United States.
The nervous system is essentially the body’s electrical wiring. It composed of nerves, which are cylindrical bundles of fibers that start from brain and central cord and branch out to every other part of body. Neurons send signals to other cells through thin fibers called axons, which cause chemicals known as neurotransmitters to be released at junctions called synapses. A synapse gives a command to the cell and the entire communication process typically takes only a fraction of a millisecond. Sensory neurons react to physical stimuli such as light, sound and touch and send feedback to the central nervous system about the body’s surrounding environment. Motor neurons, located in the central nervous system or in peripheral ganglia, transmit signals to activate the muscles or glands.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker.
Nervous system is vulnerable to various disorders. It can be damaged by Trauma Infections, Degeneration, Structural defects, Tumors, Blood flow disruption, Autoimmune disorders. Disorders of the nervous system may involve vascular disorders, Infections, Structural disorders, ors, peripheral Functional disorders, Degeneration. The overall central nervous system therapeutic drug market is valued at an estimated $78 billion in 2010. This market will experience a nominal reduction in the early portion of the forecast period, and then slowly rise at a compound annual growth rate (CAGR) of 0.7% to reach nearly $81.8 billion by 2015.
The World Health Organization (WHO) estimates that over one billion people worldwide suffer from illnesses of the central nervous system. Besides injuries of the brain and the spinal cord, these include a large number of neurological or mental illnesses, such as Parkinson’s syndrome (150,000 to 200,000 patients in Germany), dementia (estimated 1.2 million), stroke (about 250,000 annually) and epilepsy (400,000 to 800,000).
List of Best International Conferences
Related Associations and Societies
The Society for Neuroscience
Society for Neuro-Oncology
American Physiological Society (APS)
American Medical Associations
American Autonomic society
America cancer society
Canadian nuclear society
American Academy of Neurology
European Neurological Societies
World Federation of Neurology
Spanish Society of Neurology
Hilarescere Foundation in Italy
Italian MS society in Italy
Southern Clinical Neurological Society
ESNR European Society of Neuroradiology
Vision sciences society
American Association of Neurological Surgeons
Saudi Association of Neurosurgery
Emirates Medical Association
Top Market key players:
Eli Lilly & Co.
Johnson & Johnson
Merck & Co.,
Bristol-Meyers Squibb Co.
Boston Scientific Corporation
Koninklijke Philips N.V.
The World Health Organization (WHO) shows that 6.8 million people die every year as a result of neurological disorders, in Europe the economic cost of neurological diseases was estimated at about 139 billion euros in 2004. Total European 2010 cost of brain disorders was €798 billion and will grow to $480 billion by 2030
The European average cost per person with a disorder of the brain ranged between €285 for headache and €30 000 for neuromuscular disorders. Total annual cost per disorder (in billion € 2010) was as follows: addiction 65.7; anxiety disorders 74.4; brain tumor 5.2; child/adolescent disorders 21.3; dementia 105.2; eating disorders 0.8; epilepsy 13.8; headache 43.5; mental retardation 43.3; mood disorders 113.4; multiple sclerosis 14.6; neuromuscular disorders 7.7; Parkinson's disease 13.9; personality disorders 27.3; psychotic disorders 93.9; sleep disorders 35.4; somatoform disorder 21.2; stroke 64.1; and traumatic brain injury 33.0.
This covers an in-depth analysis and an estimation of the global neurology devices market, for the period of 2013 - 2029, considering 2012 as the base year for calculations. In addition, the current market dynamics including the drivers, restraints, trends and recent developments have been captured throughout the report. The neurology devices market has been further segmented into CSF management devices, interventional neurology, neurosurgery and neurostimulation devices markets.
This page will be updated regularly.
This page was last updated on December 2, 2020